TBPH
TBPH
NASDAQ · Pharmaceuticals

Theravance Biopharma Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$16.93
+0.01 (+0.06%)
As of Aug 8, 10:12 PM ET ·
Analyst Consensus
Hold
11
Analysts
Moderate
Coverage
Buy 6 55%
Hold 5 45%
Sell 0 0%
Price Target
Analyst Price Target +47.4% upside
Low Target $16.23
Average Target $24.95
High Target $30.59
Current Price $16.93
Current
$16.93
Target
$24.95
$16.23 $24.95 avg $30.59
Scenario Analysis
Bear Case
$16.23
-4.1%
Low target
Base Case
$24.95
+47.4%
Avg target
Bull Case
$30.59
+80.7%
High target
Risk/Reward
19.5x
Highly favorable
Price in Context
52-Week High
$21.03
-19.5% from high
52-Week Low
$11.05
+53.3% from low
Target vs 52W High
$24.95
+18.6% vs high
Next Earnings Report
Aug 10, 2026
Today
EPS Est: $0.05
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
 Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
 Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
 Hold 24 54% $209.87 +188.8%